Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien

COLORADO SPRINGS, Colo., Jan. 27, 2015 -- (Healthcare Sales & Marketing Network) -- The Spectranetics Corporation (SPNC) today announced it has completed the acquisition of Covidien's Stellarex(TM) drug coated balloon angioplasty (DCB) platform. The transa... Devices, Interventional, AcquisitionsSpectranetics, Covidien, Stellarex, drug coated balloon
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news